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Abstract Retinol-binding protein (RBP) functions as a trans-
porter for retinol (vitamin A) in plasma in higher eukaryotes. We
have successfully expressed human RBP in Saccharomyces
cerevisiae, and its secretion was found to be induced by retinol
also in this lower eukaryote. Reduced induction of secretion by
retinol in a temperature-sensitive sec18-1 mutant that is blocked
in secretion at the restricted temperature suggests that as in
mammalian cells, RBP can be released from the endoplasmic
reticulum upon addition of retinol. Thus, the molecular mecha-
nism involved in retinol-dependent secretion of RBP appears to
be conserved in yeast, and this points to yeast as a putative model
system for studying retinol-regulated secretion of RBP. RBP
purified from yeast was found to be indistinguishable from RBP
purified from human plasma in several functional assays.
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1. Introduction
In plasma of mammals, retinol is transported bound to a
speci¢c retinol-binding protein (RBP). The majority of RBP is
produced in the liver, but mRNA for the protein has also
been found in several extrahepatic tissues [1]. Retinol-induced
secretion of RBP has been demonstrated in human and rat
liver cells, and in human HeLa cells (which normally do not
produce RBP) transfected with an expression plasmid for rat
RBP [2]. Several authors have presented data demonstrating
that retinol de¢ciency reduces RBP secretion in vivo, and that
this does not a¡ect the mRNA level in living rats [3^5]. Com-
mon for all the systems studied is that when retinol-depleted
cells or animals are given retinol, secretion of RBP is rapidly
restored. In the absence of retinol, RBP accumulates in the
endoplasmic reticulum (ER) [6^8] probably due to speci¢c
retention mechanisms. These mechanisms are, however, not
known.
Several proteins have been found to be retained in the ER
due to signals within the proteins. Examples of such signals
include relatives of the C-terminal sequences KKXX and
KXKXX. Membrane proteins carrying these sequences are
cycled between the ER and Golgi compartments [9]. Proteins
can also be retained in the ER due to retrieval signals like the
C-terminal sequence KDEL (HDEL in yeast) [10]. Also mis-
folded or partly folded proteins can be retained by speci¢c
retention signals. Hence a protein’s folding or oligomerization
may determine if the protein is retained or not. Formation of
disul¢de bonds appears to be important for correct folding,
and in yeast, proteins containing disul¢de bonds have been
shown to be retained intracellularly in the presence of 20 mM
of the reducing agent dithiothreitol (DTT), while secretory
proteins without disul¢de bonds were not a¡ected [11]. RBP
contains three disul¢de bonds, but in contrast to secretory
proteins in yeast, its secretion from HepG2 cells is stimulated
at low levels of reducing agent [6]. Several intracellular inter-
mediate forms of RBP have been identi¢ed, termed pre-RBP,
compact I, compact II, and mature RBP [7,8]. The conversion
process from compact II to mature RBP was found to take
several hours. Thus, the rapid retinol-induced secretion of
RBP observed when retinol-depleted cells are supplemented
with retinol most likely involves rapid conversion of compact
II to a mature form of RBP which is rapidly secreted.
Secretion of both protein and low molecular signal substan-
ces have been shown to be regulated at the level of fusion of
secretory vesicles with the plasma membrane (reviewed in
[12]). However, ligand-regulated secretion, as in the case of
RBP, appears to be a more unique process, perhaps paralleled
only by the secretion of apolipoprotein B-100 (apoB) which is
secreted as a part of very low density lipoproteins (VLDL).
However, in the case of apoB secretion, triglycerides may not
act as true ligands with speci¢city for unique binding sites on
the protein. Secretion of apoB has been shown to be increased
in the presence of triglycerides and oleate which is part of the
VLDL particles. The apoB protein is rapidly degraded within
the ER in the absence of triglycerides [13^15]. This is in con-
trast to the situation for RBP which accumulates in the ER
[3,16^18] in the absence of its ligand. We have taken advan-
tage of yeast as a eukaryotic expression system to express
human RBP and shown that ligand-induced secretion of this
protein can be reproduced in yeast, and that the properties of
the secreted RBP are indistinguishable from those of RBP
puri¢ed from human plasma. This makes it possible to utilize
the numerous secretion mutants and powerful genetic proper-
ties of yeast to further investigate the molecular mechanisms
involved in retinol-induced secretion of RBP.
2. Materials and methods
2.1. Materials
N-(4-Hydroxyphenyl)retinamide (4-HPR) was a generous gift from
Dr. Richard Moon at Specialized Cancer Center, University of Illinois
at Chicago, IL, USA. Other retinoids, cycloheximide, phytol and
L-mercaptoethanol were purchased from Sigma (St. Louis, MO,
USA). Except for cycloheximide, which was dissolved in water, these
chemicals were dissolved in ethanol prior to use. Zymolyase 100T was
purchased from Seikagaku (Tokyo, Japan). Substrate for L-glucanase
(Azo-barley glucan) was purchased from Megazyme (Sydney, Austral-
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ia). DNA modi¢cation enzymes were purchased from Promega (Mad-
ison, WI, USA). DNA primers were purchased from MWG-Biotech
(Ebersberg, Germany). Antibodies were purchased from DAKO (Co-
penhagen, Denmark). Attophos substrate were purchased from JBL
(San Luis Obispo, CA, USA).
2.2. Plasmid constructs
To express RBP in yeast, a construction was made based on the
plasmid pKUXPTH-2 [19]. The BamHI-Ecl136II fragment was excised
from this construct, and replaced with a BamHI-digested PCR frag-
ment from the same plasmid made by primers I and II, leading to the
construct pPKUX39PTH. From this construct an Ecl136II-SalI frag-
ment was excised, and the SalI site of the vector was ¢lled in to create
blunt ends. Into this vector a PCR fragment encoding the mature
form of hRBP (made by primers III and IV) was inserted, giving
the construct pPKUXhRBP.
2.3. Primers
Primers I, II, III and IV used in the present study were:
I TGT GGA TCC TCT AGA GAA ATC;
II CTC TTT TAT CCA AAG ATA CCC;
III AAA GAG ACT GCA GAG TGA GCA GC;
IV CAG CTA TGA CCA TGA TTA CGA A.
2.4. Strains, transformation and culture conditions
Saccharomyces cerevisiae strains FL200 (K leu2 ura3), RSY271 (K,
sec18-1, ura3-52, his4-619) and H758 (K sec6-4 his4-260 leu2-3,112
trp1 (HindIII) ura3-52) were transformed with the pPKUXhRBP plas-
mid and cultured in 0.67% YNB without amino acids, 2% glucose, 1%
casamino acids and supplemented with amino acids (50^75 Wg/ml).
Histidine was added to 0.4% to enhance the bu¡er capacity at pH
6.0. Strain M994 (a, leu2, thr4) was transformed with PCNN-
MH(A16-M) and was cultured in 0.67% YNB without amino acids,
4% sucrose, supplemented with amino acids (50^75 Wg/ml). All strains
were transformed by a lithium salt-based method [20]. Plasmid
PCNN-MH(A16-M) and yeast strain M994 were generous gifts
from Ole Olsen and Morten Meldgaard at the Carlsberg Laboratory,
Copenhagen, Denmark. Strain RSY271 was a gift from Randy Schek-
man (University of California, Berkeley, CA, USA).
2.5. Preparation of spheroplasts
Spheroplasts were prepared by incubating yeast cells at 37‡C in a
solution of 1 M sorbitol/0.15 M phosphate bu¡er pH 7.4 with 1 mg/
ml Zymolyase 100T, and 1.4 mM L-mercaptoethanol.
2.6. Preparation of intracellular and periplasma fractions
After preparation of spheroplasts the cells were spun down and the
supernatant was taken as the periplasma fraction. The cells were
washed once in 1 M sorbitol/0.15 M phosphate bu¡er pH 7.4, before
resuspension and lysis in 0.1% SDS. This sample was taken as the
intracellular fraction.
2.7. Puri¢cation of RBP from yeast growth medium
Yeast cells were grown at 25‡C to late log phase in the presence of
10 WM retinol and concentrated to 1U109 cells/ml. The cells were then
incubated for several hours in the presence of 10 WM retinol. To
remove the cells they where pelleted twice at 10 000 rpm in a SS34
rotor (Sorvall) for 5 min. RBP was concentrated using Ultrafree with
a cuto¡ of 5 kDa. Subsequently RBP was puri¢ed from the concen-
trated sample by gel ¢ltration on a Superdex 75 10/30 column (Phar-
macia).
2.8. Puri¢cation of RBP from human plasma
RBP was puri¢ed from plasma essentially as described [21]. The
procedure involves three steps: chromatography on DEAE Sepharose
Fast Flow, followed by gel ¢ltration on a HiLoad 26/60 Superdex 200
prep grade column and ¢nally a⁄nity chromatography on a NHS
activated HiTrap column with coupled TTR (Pharmacia) according
to instructions from the manufacturer.
2.9. Labeling of RBP
RBP was iodinated at Tyr residues of RBP using Iodo-Beads ac-
cording to instructions from the manufacturer.
2.10. Receptor-binding assay
The assay was performed by measuring bound 125I-RBP to placenta
vesicles using an oil-centrifugation method as described [22]. Three
parallel incubations were done in presence and absence of 2 WM un-
labeled RBP puri¢ed from plasma. Human placenta vesicles were
prepared as described [23].
2.11. Assay for secreted RBP and L-glucanase
Yeast cells were grown to late log phase (5U107^1U108 cells/ml) in
shake £ask cultures at 30‡C. Cells were washed once in growth me-
dium at 30‡C before resuspension in growth medium at 1U109 cells/
ml containing 0.1 mg/ml cycloheximide. Aliquots of 10 ml were then
transferred to 50 ml tubes, and placed in a shaker at 30‡C. Retinoids
or other chemicals were then added, and aliquots were taken at in-
dicated time points for immediate separation of cells from growth
medium by centrifugation. RBP was quanti¢ed by immunoblotting
as described [24] except for blotting onto PVDF membranes instead
of on nitrocellulose. The relative intensity of the bands from immu-
noblotting was detected by densitometry or £uorography. L-Gluca-
nase was assayed as described [25].
2.12. Electrophoresis
Electrophoresis was performed under reducing conditions in the
presence of 0.1% SDS on commercially available 14% Tris-glycine
gels (Novex).
2.13. Immunoblotting
Immunoblotting was done as described [24]. When Attophos was
used as a substrate, alkaline phosphatase conjugated to pig anti-rabbit
immunoglobulins was used as secondary antibody. Attophos was used
according to instructions from the manufacturer.
FEBS 20194 7-5-98
Fig. 1. Schematic representation of expression plasmids. The plasmids pPKUXhRBP and PCNN-MH(A16-M) direct expression and secretion of
hRBP and (1-3,1-4)-L-glucanase, respectively, in yeast.
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2.14. Silver staining
Staining with silver was done as described [26].
3. Results
To examine whether retinol-regulated secretion as it is ob-
served in mammalian cells is conserved in S. cerevisiae, yeast
cells were transformed with a plasmid that directs expression
of RBP under the control of the constitutive MFK1 promoter
(Fig. 1). The MFK1 pro-region contains the basic sequence
Lys-Arg that is recognized by the KEX2-encoded endopro-
tease yscF residing in the Golgi region [27]. Cleavage of the
fusion protein by the KEX2-encoded enzyme would thus give
RBP with a correct N-terminus.
3.1. E¡ect of incubation time on secretion of RBP in yeast
Yeast cells containing pPKUXhRBP were incubated in the
presence and the absence of retinol and samples from the
growth medium were collected after various time points and
analyzed with Western blotting with anti-hRBP antibodies as
described in Section 2. The results are shown in Fig. 2A. It is
clear that much more RBP was secreted from the transformed
yeast in the presence of retinol compared to the control. In-
terestingly, retinol was most e¡ective in inducing secretion of
RBP the ¢rst 15 min after addition of retinol. The e¡ect of
retinol on secretion is independent of transcription and trans-
lation since these experiments were carried out in the presence
of cycloheximide. As can be seen in Fig. 2, secretion also
occurs in the absence of retinol. This is in line with results
obtained with mammalian cells, where moderate levels were
found to be secreted also in the absence of retinol [28,29]. To
rule out the possibility that retinol has a more general stim-
ulatory e¡ect on secretion of proteins in yeast, we tested the
e¡ect of retinol on secretion of (1-3,1-4)-L-glucanase. Yeast
cells were transformed with a plasmid containing the gene
for L-glucanase under control of the PRB1 promoter
[27,30,31]. The cells were then incubated with retinol or phytol
for increasing time periods. The results (Fig. 2B) show that
retinol has no e¡ect on the secretion of L-glucanase. Also
secretion of (1-3,1-4)-L-glucanase in the presence of ethanol
(solvent for phytol and retinol) was comparable to that in the
presence of phytol and retinol (data not shown), demonstrat-
ing that retinol does not have a general stimulatory e¡ect on
protein secretion in yeast.
3.2. The e¡ect of other retinoids and L-mercaptoethanol
on secretion of RBP
To determine whether the secretion of RBP to the growth
medium can be induced by some other retinoids as has pre-
viously been observed in rat and human cells, we incubated
transformed yeast cells in the presence of retinol, retinal or
retinoic acid or the synthetic retinoid 4-HPR, which have all
been found to bind to RBP [32,33]. Also the e¡ect of L-mer-
captoethanol was tested. Retinoic acid has been shown to
stabilize folding intermediates of RBP in the same way as
retinol [7,8] and to promote secretion of RBP in retinol de¢-
cient primary hepatocytes [28]. Retinal has been found to
stimulate secretion of RBP in HeLa cells in vitro [2], and
L-mercaptoethanol stimulates secretion of RBP in HepG2
cells [6]. Growth media from the cells incubated with the
di¡erent substances were collected and RBP secreted was
measured by quantitative Western analysis. The results in
Fig. 3 show that retinol was most potent in stimulating secre-
tion of RBP to the growth medium. 4-HPR seems to be nearly
as e⁄cient as retinol in stimulation of secretion, which is in
agreement with results obtained with HepG2 cells [34] and
liver cells in vivo [35], where retinol and 4-HPR had compa-
rable e¡ects on stimulation of secretion. Retinal and retinoic
acid also stimulates the secretion of RBP although not as
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Fig. 2. Time course comparing secretion of hRBP in the presence
and absence of retinol. Transformed yeast cells were incubated with
10 WM retinol or ethanol as described in Section 2. Samples from
cultures expressing hRBP were subjected to immunoblotting at vari-
ous time points. The same amount of growth medium was added to
each lane. A: In the upper part of the panel a typical Western blot
of hRBP are presented. Yeast cell cultures where incubated in the
presence and absence of retinol as indicated. Samples for Western
analysis were taken after indicated times of incubation. The relative
amounts of hRBP were quantitated at indicated time points by
Western analysis and densitometry. Error bars represent standard
error of the mean from three di¡erent experiments. Values obtained
in the absence of retinol at 120 min was chosen as 100%, other val-
ues are presented as percentages of this value. White bars represent
control while black bars represent presence of retinol. B: The cul-
tures expressing L-glucanase were analyzed by a method based on
degradation of a dyed Azo-barley glucan substrate to fragments
which are soluble in the presence of precipitant solution. The ab-
sorbance at 490 nm is thus proportional to L-glucanase activity
which was measured at indicated time points in presence of 10 WM
phytol or 10 WM retinol. Error bars represent standard error of the
mean from three replicates in one typical experiment.
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e⁄ciently as retinol and 4-HPR. The e¡ect of L-mercapto-
ethanol on RBP secretion in yeast is not pronounced.
3.3. Intracellular retention of RBP in yeast
RBP expressed in yeast is clearly secreted to a larger extent
in the presence of retinol as compared to in the absence of
retinol. As expression of RBP is not altered as a function of
retinol, RBP has to be retained in a cell associated compart-
ment, either intracellularly or in the periplasma in the absence
of retinol. To determine where RBP is retained, a periplasmic
fraction, an intracellular fraction and the growth medium
were prepared as described and the fractions were character-
ized with respect to the presence of RBP. The Western blot
analysis of these fractions shows (Fig. 4) that there are several
RBP-related forms found in the intracellular as well as the
periplasmic fraction. RBP secreted to the medium migrates
as hRBP puri¢ed from plasma and is most likely identical
to hRBP. The bands that migrate faster than the standard
hRBP puri¢ed from plasma are probably degradation prod-
ucts, while those of higher molecular weight could be due to
incomplete processing of the pro-region by the KEX2-encoded
protease. The majority of RBP and RBP-related proteins are
retained intracellularly, while some RBP is also retained in the
periplasmic space. Quantitative analysis on a FluorImager
(Vistra) indicates that only 5% of the band comigrating with
puri¢ed plasma RBP is released to the growth medium.
3.4. Secretion of RBP from temperature-sensitive sec mutants
A relatively large fraction of the expressed RBP is retained
in intracellular and the periplasmic space. The observed in-
crease in secretion upon addition of retinol could be explained
by release from both compartments. To clarify whether secre-
tion of RBP was induced from the periplasmic space or from
an intracellular compartment, secretion of RBP was studied in
a yeast strain with a temperature-sensitive secretion phenotype
(sec18-1). The secretion from the sec18-1 mutant strain
RSY271 is blocked at the non-permissive temperature
(37‡C) whereas secretion is apparently normal at the permis-
sive temperature (25‡C) [36]. The secretion of RBP from this
mutant was compared to that of FL200 (which is wild-type
with respect to secretion) at 25‡C and 37‡C.
If retinol-dependent release of RBP in yeast is due to release
of RBP from the ER, secretion in the sec mutant should be
strongly reduced at 37‡C as compared to 25‡C, and retinol-
induced secretion should take place at 25‡C but not at 37‡C.
First the cells were grown for 24 h at 25‡C, where both the
FL200 and the RSY271 display wild-type phenotype. Then
the cells were split and incubated for 2 h at the permissive
or non-permissive temperature, and RBP in the growth me-
dium was analyzed by Western blotting (Fig. 5B). The results
show that the pattern of secretion from the sec18-1 mutant
strain RSY271 is consistent with retinol-induced secretion
from the ER and not the periplasm. In the presence of retinol
the immunoreactive bands containing RBP was signi¢cantly
reduced when incubated at 37‡C compared with incubation at
25‡C.
More important, a clear di¡erence between the presence
and the absence of retinol was found at 25‡C whereas no
di¡erence was found at 37‡C (this applies also when all im-
munoreactive bands are grouped (Fig. 5A)). This would not
have been the case if retinol induced release of RBP from the
periplasma. This experiment also demonstrated that high mo-
lecular weight forms of RBP (marked * and ** in Fig. 5B)
were secreted to a lesser extent at 25‡C than at 37‡C in FL200
as well as in the RSY271 strain. The bands marked * and **
are probably due to incomplete cleavage between the MFK1
pro-region and RBP by the KEX2-encoded protease. O-Gly-
cosylation is a less likely explanation for this band, as this
would require glycosylation of most of the 11 Ser and 9 Thr
residues of RBP.
Release of RBP to the growth medium was also tested in
another sec18-1 strain as well as in sec6 and sec1 mutants at
permissive and non-permissive temperatures. Secretion from
the sec6 mutant resembled that of RSY271, while the results
with the two other strains were inconclusive as more RBP was
released at 37‡C as compared to the RSY271 strain (data not
shown).
3.5. RBP secreted from yeast has similar binding properties as
RBP from human serum
When RBP is expressed in yeast from the pPKUXhRBP
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Fig. 4. Distribution of RBP between extracellular and intracellular
compartments. Growth medium, the periplasmic fraction and the in-
tracellular fraction from 3U107 cells cultured in the presence of reti-
nol and cycloheximide were subjected to SDS-PAGE and immuno-
blotting. As control, fractions were prepared from the same number
of cells not transfected with pPKUXhRBP.
Fig. 3. E¡ects of retinoids and other substances on secretion of
hRBP. Transformed yeast cells were incubated in 10 WM of the in-
dicated substances (except ethanol) as described in Section 2. Sam-
ples were collected for analysis by immunoblotting after 30 min of
incubation. The relative amounts of hRBP after incubation with
various substances were quanti¢ed with densitometric analysis on
immunoblots. The results shown are mean of four or ¢ve individual
experiments where values obtained with ethanol were set at 100%.
Error bars represent standard error of the mean from di¡erent ex-
periments.
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construct, the protein undergoes several processing steps on
its way through the secretory pathway due to its fusion to the
MFK1 pro-region. These processing events take place in dif-
ferent compartments. As these processing events in S. cerevi-
siae may result in di¡erent forms of RBP, it is important to
verify that the secreted protein has the same properties as the
protein secreted from mammalian cells. Therefore, we sub-
jected RBP secreted to the yeast growth medium to character-
ization with respect to the biological function of RBP, i.e.
retinol binding, binding to TTR and binding to RBP receptors
in placenta vesicles. With respect to these biological functions,
RBP puri¢ed from the growth medium of transfected yeast
cells had similar receptor-binding a⁄nity as RBP puri¢ed
from plasma (Fig. 6C). The Kd for the interaction between
RBP and its receptor was found to be 34.5 nM, which is
similar to the value (i.e. 79 nM) observed by Sivaprasadarao
and Findlay [37]. The secreted RBP did also interact with
retinol and TTR as shown (Fig. 6A,B). Although these data
do not directly determine the binding a⁄nity of RBP to ret-
inol and TTR, they clearly demonstrate that the protein in-
teracts with retinol and TTR.
4. Discussion
In this work we describe how retinol-binding protein is
expressed and secreted in S. cerevisiae transfected with a
plasmid encoding human RBP. Secretion of many proteins
by mammalian cells appears to be a regulated process. For
example, in mouse mammary cells casein secretion is to some
extent regulated by the intracellular Ca2 concentration. In
the absence of stimulation, casein appears to be accumulated
in secretory vesicles [38]. In hepatic cells apolipoprotein
B-100 is secreted upon incubation of cells with triglycerides
and this protein is degraded within the ER when secretion is
not stimulated [18]. Retinol-induced secretion of RBP
from the liver in vivo and from hepatocytes and transfected
non-hepatic cells in vitro have been described in several
studies [16,29,39,40]. When secretion is not induced by
retinol, RBP is retained and accumulates in the ER [3,6].
This type of ligand-induced secretion seems so far to be
unique for RBP and the mechanisms involved are poorly
understood.
Our results clearly demonstrate that RBP secretion from
the yeast cells can be induced with RBP’s physiologically
functional ligand, retinol. One implication of these results
is that the retention mechanisms involved in keeping RBP in
the ER in the absence of its ligand is conserved even in
organisms where retinol appears to play no role for the via-
bility or function of the organism. Moreover, RBP secreted
from yeast cells is indistinguishable from human plasma RBP
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Fig. 5. Secretion of RBP from sec mutants. A: Cultures of strain FL200 and the sec18-1 mutant RSY271 were grown at 25‡C to late log
phase. The cultures were then split, and washed and concentrated to 109 cells/ml before incubation at 25‡C or 37‡C in the presence or absence
of 10 WM retinol for 30 min. The same amount of medium from each incubation was then subjected to SDS-PAGE and immunoblotting.
B: The immunoblot in A was analyzed by densitometry and the relative amounts of RBP secreted under di¡erent conditions were plotted. The
amount of RBP secreted from cells incubated at 25‡C with no retinol was set at 100%. Error bars represent standard error of the mean from
three di¡erent experiments.
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in terms of retinol binding, TTR binding and binding to cell
surface receptors on mammalian cells.
Our interpretation of the data for the RSY271 strain in Fig.
5 is as follows: RBP is made as a pre-pro precursor. As the
precursor is transported into the ER the signal sequence is
cleaved o¡. The resulting pro-RBP is then transported to
the Golgi compartment before processing of the pro-region
by the KEX2-encoded protease, which resides in trans-Golgi.
At 37‡C however, secretion is blocked between ER and Golgi,
and whatever comes out of the cell at the non-permissive
temperature is released from a post-ER compartment. The
same set of di¡erent RBP forms are seen in RSY271 as in
periplasma and the intracellular compartment of the FL200
strain at both permissive and non-permissive temperatures
(Fig. 5B), indicating that the RBP forms released to the me-
dium at the non-permissive temperature could come from the
Golgi or the periplasmic space.
Mechanisms involved in folding, ER retention and secretion
of proteins has been studied in great detail in S. cerevisiae and
our results showing that retinol-induced secretion of RBP can
be reproduced in this organism opens up the possibility of
studying this process in yeast strains where one or several
components required for folding, retention and secretion
have been mutated.
RBP could possibly be retained in the ER by its association
to other proteins that are retained by the well characterized
mechanisms based on the KDEL (HDEL) or KKXX motifs
as both these mechanisms are conserved between yeast and
mammalian cells [10]. We have recently found that the RNLL
sequence in the C-terminal of RBP, although similar to a
KDEL motif, is not responsible for its intracellular retention
[29]. RBP has under certain conditions been found associated
with calnexin [41], which is considered to be a part of an
apparatus responsible for control of protein conformation in
the ER [42,43] and thus calnexin could be responsible for
RBP’s retention in the absence of its ligand. This association
was, however, detected only when RBP was exposed to reduc-
ing agents, which may induce alterations in RBP’s conforma-
tion and may therefore not be involved under the normal
conditions. A member of the calnexin/calreticulin family of
genes has recently been described by Parlati et al. They have
named the gene CNE1 and made strains with a disruption in
this gene [44]. By transfecting these mutant strains with our
expression vector it is possible to study the involvement of this
member of the calnexin family in retention of RBP.
Formation of disul¢des during folding of newly synthesized
and translocated RBP has been implicated in retention and
retinol-induced secretion. Kaji and Lodish have found that
RBP goes through several intermediate conformations during
folding and that retinol stabilizes certain disul¢de con¢gura-
tions in RBP [7,8]. This is in line with the observation that
L-mercaptoethanol modi¢es secretion of RBP from HepG2
cells [6]. The reason why L-mercaptoethanol has little e¡ect
on secretion of RBP in yeast could be that secretory proteins
containing disul¢de bonds have been shown to be retained
intracellularly in yeast in the presence of reducing agents
[11]. Formation and rearrangements of disul¢des in mamma-
lian cells and yeast are mediated by protein disul¢de isomer-
ase (PDI). Indeed, PDI has been shown to enhance the rate of
unfolding of RBP by DTT in vitro [8]. As yeast strains with
mutations in PDI have already been described [45], this enzy-
me’s role in retention and secretion of RBP can be studied by
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Fig. 6. Binding properties of RBP secreted from yeast cells. A:
Binding of retinol to RBP. [3H]Retinol-labeled RBP (0.5 ml) was
loaded onto a Superose 12 column before (triangles) and after
(squares) incubation with cold retinol. The samples were eluted with
phosphate bu¡ered saline (PBS) pH 7.4 at 0.5 ml/min. Fractions of
0.5 ml were collected and 10 Wl of each fraction were counted. The
arrow marked RBP denotes the fraction in which plasma-puri¢ed
RBP was eluted in a parallel experiment. B: Binding of RBP to
TTR. [3H]Retinol-labeled RBP in PBS was loaded onto a TTR col-
umn (TTR coupled to a 1 ml NHS-activated HiTrap column (Phar-
macia)). The column was washed with 5 ml PBS and eluted with
water adjusted to pH 10 with NH3. The radioactivity in 10 Wl of
each fraction was counted. The arrow marked RBP indicates the
fraction in which plasma puri¢ed RBP was eluted in a parallel ex-
periment. C: Receptor binding. Placenta vesicles (1 mg/ml) were in-
cubated with various concentrations of 125I-RBP at 22‡C for 15 min,
and bound RBP was plotted against concentration of RBP during
binding. The binding data were then subjected to a Scatchard plot
(insert). The calculated Kd and Bmax were 34.5 nM and 590 fmol of
RBP bound/mg of membrane protein, respectively. The data repre-
sent mean values of three experiments.
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transfection of these mutant strains with our expression vector
and our assay for retinol induced secretion.
Additionally, yeast may be used for expression and puri¢-
cation of RBP for functional studies. Small amounts (approx.
200 Wg/l) of RBP can be obtained in its functional form when
it is expressed in Escherichia coli [46], whereas we can obtain
10 times more RBP in the concentrated yeast growth medium.
This RBP can be either holo- or apo-RBP and it can be
labeled to high speci¢c activity with [35S]methionine. This is
important for studies of RBP-receptor interactions as iodina-
tion of RBP has been shown to modify its behavior in cellular
binding, uptake and degradation [47]. In summary, this work
describes and characterizes some of the tools required for
elucidating the mechanisms responsible for ligand-induced se-
cretion of RBP.
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